JP3217861B2 - Materials for treating periodontal disease - Google Patents

Materials for treating periodontal disease

Info

Publication number
JP3217861B2
JP3217861B2 JP20714892A JP20714892A JP3217861B2 JP 3217861 B2 JP3217861 B2 JP 3217861B2 JP 20714892 A JP20714892 A JP 20714892A JP 20714892 A JP20714892 A JP 20714892A JP 3217861 B2 JP3217861 B2 JP 3217861B2
Authority
JP
Japan
Prior art keywords
lactic acid
membrane
copolymer
periodontal disease
present
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
JP20714892A
Other languages
Japanese (ja)
Other versions
JPH0638992A (en
Inventor
誠 横田
浩三 久保田
隆雄 岡田
陽一 永岡
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Taki Kasei Co Ltd
Original Assignee
Taki Kasei Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Taki Kasei Co Ltd filed Critical Taki Kasei Co Ltd
Priority to JP20714892A priority Critical patent/JP3217861B2/en
Publication of JPH0638992A publication Critical patent/JPH0638992A/en
Application granted granted Critical
Publication of JP3217861B2 publication Critical patent/JP3217861B2/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Landscapes

  • Dental Tools And Instruments Or Auxiliary Dental Instruments (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Dental Preparations (AREA)

Description

【発明の詳細な説明】DETAILED DESCRIPTION OF THE INVENTION

【0001】[0001]

【産業上の利用分野】本発明は歯周病治療用素材に関
し、殊に歯周疾患の外科的処置治療及びインプラント治
療時に行う骨増大術に際して有用なる素材を提供するこ
とを目的とするものである。
BACKGROUND OF THE INVENTION 1. Field of the Invention The present invention relates to a material for treating periodontal disease, and more particularly to providing a material useful for bone augmentation performed during surgical treatment and implant treatment for periodontal disease. is there.

【0002】[0002]

【従来の技術】歯周疾患により破壊された歯周組織の良
好な再生を行なう歯周外科処置方法については、従来よ
り歯根面の歯根膜由来細胞の増殖を促進し、上皮細胞、
歯肉由来細胞あるいは骨由来細胞の侵入を抑制すること
が有効であることが知られている(Milcherら,J. Period
ontol., 47,256(1976))。このことから、その処置療方
法として、ミリポアフィルター(MILLIPORE FILTER,ミリ
ポア社商品名)によって、歯根面への上皮細胞等の侵入
を抑制し、歯根膜細胞の増殖に必要な空間を形成させる
方法がGTR法(Guided Tissue Regeneration法)として
知られている(Nymanら,J. Clin. Periodontol.,9,290(1
982))。また、この方法の臨床への応用例として、生体
内で非分解性である多孔性ポリテトラフルオロエチレン
膜(コ゛ア テックス膜,ゴア社商品名)が知られている。しかし
ながら、このGTR法は術式的に熟練が必要であり、ま
た一定期間後には再び術部の外科処置を行ない、術部に
埋入した膜を摘出する必要があるため、患部周辺への損
傷を生起し易い。このようなことから生体内へ埋入後に
於て再手術の必要がない、生体内分解性を有する膜材料
が所望されている。
2. Description of the Related Art Periodontal surgery methods for satisfactorily regenerating periodontal tissue destroyed by periodontal disease have conventionally promoted the proliferation of periodontal ligament-derived cells on the root surface,
It is known that it is effective to suppress the invasion of gingival or bone-derived cells (Milcher et al., J. Period.
ontol., 47 , 256 (1976)). From this, as a treatment and treatment method, there is a method of suppressing the invasion of epithelial cells and the like to the root surface by using a Millipore Filter (Millipore Filter, trade name) and forming a space necessary for the proliferation of periodontal ligament cells. Known as the GTR method (Guided Tissue Regeneration method) (Nyman et al., J. Clin. Periodontol., 9 , 290 (1
982)). As a clinical application example of this method, a porous polytetrafluoroethylene membrane (Coretex membrane, trade name of Gore) which is non-degradable in vivo is known. However, this GTR method requires operative skill, and after a certain period of time, it is necessary to perform a surgical operation on the surgical site again and to remove the membrane embedded in the surgical site, so that there is no damage to the affected area. Easy to occur. Therefore, a biodegradable membrane material that does not require reoperation after implantation into a living body is desired.

【0003】この生体内で分解性を有する膜材料に関し
ては、天然高分子であるコラーゲン膜あるいは合成高分
子の脂肪族ポリエステルである乳酸系重合体膜が知られ
ている。しかしながら、コラーゲン膜はその分解が生体
内酵素による酵素分解によって進行することから分解速
度が一定せず、またコラーゲン中に残存しているテロペ
プタイドによって、生体に対し組織反応を生じる問題が
ある。このことから、その分解がエステル結合の加水分
解が主反応であって、生体内分解性に定常性があり、ま
た分解生成物も一般に代謝系に存在する成分となる乳酸
系重合体の応用が最近では主流となっている。
[0003] As for the membrane material which is degradable in vivo, a collagen film which is a natural polymer or a lactic acid-based polymer film which is an aliphatic polyester of a synthetic polymer is known. However, there is a problem that the degradation rate of the collagen membrane is not constant because the degradation proceeds by enzymatic degradation by an enzyme in the living body, and a tissue reaction occurs in the living body due to the telopeptide remaining in the collagen. From this fact, the main reaction is the hydrolysis of the ester bond, which has a constant biodegradability, and the application of lactic acid-based polymers, in which the degradation products are also generally present in the metabolic system, is important. Recently it has become mainstream.

【0004】このような乳酸系重合体を応用した材料と
して、L-乳酸重合体膜(Magnussonら,J. Periodontol.,5
9,1(1988))、100μmの孔を有する乳酸-グリコール酸共
重合体であるバイクリル メッシュ(Vicryl mesh,Polygl
actin 910,エチコン社商品名)(Fleisherら,Int. J. Per
io. Rest. Dent., 2,45(1988))、L-乳酸重合体膜及び乳
酸-グリコール酸共重合体膜(久保田ら,日歯周誌,31,870
(1989))等が知られており、これらの材料を用い保護膜
として使用することが報告されている。更に、特開平2-
63465号公報では、乳酸-グリコール酸共重合体、乳酸-
ε-カプロラクトン共重合体を素材とした材料を使用す
ることが知られている。しかしながら、これら乳酸系重
合体材料は、その膜が硬質であるため歯牙表面へ膜を固
定することが非常に困難であり、歯牙面と膜との密着性
に問題がある。従って、このような膜を装着した場合、
上皮細胞等の侵入や歯肉等の圧迫により、膜の離脱、剥
離等を生じた。
As a material using such a lactic acid-based polymer, an L-lactic acid polymer film (Magnusson et al., J. Periodontol., 5
9 , 1 (1988)), a lactic acid-glycolic acid copolymer having 100 μm pores, Vicryl mesh, Polygl
actin 910, Ethicon company name) (Fleisher et al., Int. J. Per
io. Rest.Dent., 2 , 45 (1988)), L-lactic acid polymer film and lactic acid-glycolic acid copolymer film (Kubota et al., Nihon Gingaku, 31 , 870)
(1989)), and the use of these materials as a protective film has been reported. Furthermore, JP-A-2-
No. 63465 discloses a lactic acid-glycolic acid copolymer, lactic acid-
It is known to use a material made of ε-caprolactone copolymer. However, since these lactic acid-based polymer materials have a hard film, it is very difficult to fix the film to the tooth surface, and there is a problem in adhesion between the tooth surface and the film. Therefore, when such a membrane is attached,
The invasion of epithelial cells and the like and the compression of gingiva and the like caused detachment and detachment of the membrane.

【0005】このような乳酸重合体からなる保護膜材料
と歯牙面との密着性を改善する方法として、本発明者ら
は乳酸及び/又はグリコール酸の(共)重合体にアルコー
ルを含有せしめた材料が歯周病治療用素材として優れる
ことを見いだし、先に出願を行った(特願平3-237465号)
が、実用面で以下の問題点が明かとなった。即ち、こ
の素材を軟化するために使用時に加温するが、アルコー
ル含有物の加温を使用者が好まないこと。作業上、更
に柔軟性があった方が好ましいことアルコールの揮散
により素材の貯蔵安定性が必ずしも充分でないこと。
As a method for improving the adhesion between the protective film material made of such a lactic acid polymer and the tooth surface, the present inventors have added alcohol to a (co) polymer of lactic acid and / or glycolic acid. The material was found to be excellent as a material for treating periodontal disease, and was filed earlier (Japanese Patent Application No. 3-237465).
However, the following problems became apparent in practical use. That is, the material is heated at the time of use in order to soften the material, but the user does not like to heat the alcohol-containing material. It is preferable that the material has more flexibility in operation. The storage stability of the material is not always sufficient due to evaporation of alcohol.

【0006】[0006]

【発明が解決しようとする課題】そこで、本発者らは更
に検討を重ね、柔軟性に優れ、貯蔵安定性も良く、しか
も上皮細胞等の侵入や歯肉等の圧迫により膜の離脱、剥
離が生じない密着性に優れた歯周病治療用素材を得るべ
く鋭意研究を重ねた結果、クエン酸トリエチルを乳酸重
合体又は乳酸とグリコール酸との共重合体に含有させた
ものが優れた歯周病治療素材となることを見い出し本発
明に到達したものである。
Accordingly, the present inventors have further studied and found that the membrane is excellent in flexibility and storage stability, and the detachment and detachment of the membrane due to invasion of epithelial cells and the like and compression of gingiva and the like. As a result of intensive studies to obtain a material for treating periodontal disease with excellent adhesion that does not occur, it is found that those containing triethyl citrate in a lactic acid polymer or a copolymer of lactic acid and glycolic acid have excellent periodontal The present invention has been found to be a material for treating diseases and has reached the present invention.

【0007】[0007]

【課題を解決するための手段】即ち本発明は、主構成成
分として、乳酸重合体又は乳酸とグリコール酸との共重
合体にクエン酸トリエチルを含有せしめた成分からなる
歯周病治療用素材に関する。
That is, the present invention relates to a material for treating periodontal disease comprising, as a main component, a component obtained by adding triethyl citrate to a lactic acid polymer or a copolymer of lactic acid and glycolic acid. .

【0008】[0008]

【作用】本発明の素材は、主構成成分として乳酸重合体
又は乳酸とグリコール酸との共重合体にクエン酸トリエ
チルを含有せしめた素材である。本発明の素材は、乳酸
系重合体からなる多孔性分解性膜、即ち乳酸及び/叉は
グリコール酸の共重合体からなる膜素材と歯牙との間に
充填して使用することにより、生体内分解性膜の離脱、
剥離を生じず、その密着性を改善し、以て歯周組織を良
好に再生することを目的とする。
The material of the present invention is a material obtained by adding triethyl citrate to a lactic acid polymer or a copolymer of lactic acid and glycolic acid as a main component. The material of the present invention can be used in vivo by filling it between a tooth and a porous decomposable membrane made of a lactic acid-based polymer, that is, a membrane material made of a copolymer of lactic acid and / or glycolic acid. Detachment of degradable membrane,
An object of the present invention is to improve the adhesion without causing peeling and to regenerate the periodontal tissue favorably.

【0009】この素材の製造に使用する原料である、乳
酸重合体又は乳酸とグリコール酸との共重合体に関して
は、DL-乳酸の重合体、L-乳酸-グリコール酸の共重合
体、DL-乳酸-グリコール酸の共重合体を使用する。また
これら原料の内、乳酸とグリコール酸との共重合体につ
いては、その組成はL-乳酸-グリコール酸の共重合体の
場合には、L-乳酸共重合体のL-乳酸含量は20〜80モル
%、DL-乳酸-グリコール酸の共重合体の場合には、DL-乳
酸含量は20モル%以上の範囲のものを使用する。
Regarding the lactic acid polymer or the copolymer of lactic acid and glycolic acid, which is a raw material used for producing this material, a polymer of DL-lactic acid, a copolymer of L-lactic acid-glycolic acid, A lactic acid-glycolic acid copolymer is used. Further, among these raw materials, the copolymer of lactic acid and glycolic acid has a composition of L-lactic acid-glycolic acid copolymer, and the L-lactic acid copolymer has an L-lactic acid content of 20 to 80 mol
%, In the case of a copolymer of DL-lactic acid-glycolic acid, use a DL-lactic acid content of 20 mol% or more.

【0010】これらの乳酸重合体又は乳酸とグリコール
酸との共重合体は、公知のいずれの方法で製造したもの
であってもよい。例えば、乳酸、グリコール酸を酸化亜
鉛等の触媒の存在下でオリゴマーから環状二量体を得た
後、これをジエチル亜鉛、塩化スズ等の触媒存在下で開
環重合を行なうことにより得ることができる。また、本
発明で使用する乳酸重合体又は乳酸とグリコール酸との
共重合体の分子量に関しては、その数平均分子量が10,0
00〜90,000のものを使用する。即ち、分子量がこの範囲
の共重合体を使用することにより、これに後述するクエ
ン酸トリエチルを含有させた場合に、本発明の最も優れ
た歯周病用治療素材を得ることができる。本発明歯周病
治療用素材は、前述のような乳酸系重合体からなる生体
内分解性膜と歯牙との間隙に充填されるものであること
から、その特性として適度の粘弾性と曳糸性が要求さ
れ、ゴム状で或いは曳糸性を有することが要求され、こ
の特性はその共重合体の分子量に関係する。
[0010] These lactic acid polymers or copolymers of lactic acid and glycolic acid may be those produced by any known method. For example, lactic acid and glycolic acid can be obtained by obtaining a cyclic dimer from an oligomer in the presence of a catalyst such as zinc oxide and then performing ring-opening polymerization in the presence of a catalyst such as diethyl zinc and tin chloride. it can. Further, regarding the molecular weight of the lactic acid polymer or the copolymer of lactic acid and glycolic acid used in the present invention, the number average molecular weight is 10,0.
Use 00-90,000. That is, by using a copolymer having a molecular weight in this range, the best therapeutic material for periodontal disease of the present invention can be obtained when triethyl citrate described later is added thereto. Since the material for treating periodontal disease of the present invention is filled in the gap between the biodegradable membrane composed of the lactic acid-based polymer and the tooth as described above, it has moderate viscoelasticity and spinning as its characteristics. It is required to be rubbery or spinnable, and this property is related to the molecular weight of the copolymer.

【0011】従って、その分子量が10,000を下廻ると、
得られる歯周病用治療素材は室温で流動性のものとな
り、生体内分解性膜と歯牙の間隙から流出することか
ら、その使用が困難となる。またpH7.4のリン酸緩衝液
に37℃、24時間の浸漬により体積が2倍に膨潤してしま
う物性を示し、これは生体内において、体液によって膨
張し強度が下がることを意味する。反対に、共重合体の
分子量が90,000を上廻ると、得られる歯周病用治療素材
は硬く、生体内分解性や付着性が悪くなり好ましくな
い。
Therefore, when its molecular weight is below 10,000,
The resulting periodontal disease treatment material becomes fluid at room temperature and flows out of the gap between the biodegradable membrane and the tooth, making its use difficult. In addition, it exhibited the property of swelling twice in volume when immersed in a pH 7.4 phosphate buffer at 37 ° C. for 24 hours, which means that the body fluid expands in vivo and the strength is reduced. Conversely, if the molecular weight of the copolymer exceeds 90,000, the resulting periodontal disease-treating material is hard, and is poor in biodegradability and adhesion, which is not preferable.

【0012】これらの原料を使用し、本発明の主構成成
分となる乳酸重合体又は乳酸とグリコール酸との共重合
体にクエン酸トリエチルを含有せしめた成分からなる歯
周病用治療素材を製造する方法は次の通りである。先
ず、乳酸重合体又は乳酸とグリコール酸との共重合体を
150μm程度以下に粉砕または裁断する。そして、それを
塩化メチレン又はクロロホルムやアセトン等ポリマーが
溶解する溶媒に溶解させる。次に、この溶液にクエン酸
トリエチルを乳酸重合体又は乳酸とグリコール酸との共
重合体に対して1/2倍量程度添加し、室温〜70℃程度の
温度で約1時間攪拌分散させる。溶媒の一部が揮発し、
クエン酸トリエチルが乳酸重合体又は乳酸とグリコール
酸との共重合体に十分に均一化した状態になったところ
で室温〜70℃で真空乾燥する。また有機溶媒を用いず乳
酸重合体又は乳酸とグリコール酸との共重合体を100〜1
50℃に加温し軟化した後、クエン酸トリエチルを攪拌分
散させることもできる。この場合に於てクエン酸トリエ
チル含量は、乳酸共重合体又は乳酸とグリコール酸の共
重合体に対し10〜40重量%の範囲であることが必要であ
って、この範囲を逸脱するクエン酸トリエチル含量で
は、本発明の優れた歯周病用治療素材を得ることが困難
となる。即ち、クエン酸トリエチル含量が10重量%を下
廻ると、素材が軟化せず、生体内分解性膜への付着性が
低下し、生体内分解性膜と歯牙との間に隙を生じる。ま
た反対に、クエン酸トリエチル含量が40重量%を上廻る
と、素材が体液等の水分により溶解することから好まし
くない。
Using these raw materials, a therapeutic material for periodontal disease comprising a component obtained by adding triethyl citrate to a lactic acid polymer or a copolymer of lactic acid and glycolic acid as a main component of the present invention is produced. The method for doing this is as follows. First, a lactic acid polymer or a copolymer of lactic acid and glycolic acid is used.
Crush or cut to less than 150μm. Then, it is dissolved in a solvent in which the polymer dissolves, such as methylene chloride or chloroform or acetone. Next, triethyl citrate is added to this solution in an amount about 1/2 the amount of the lactic acid polymer or the copolymer of lactic acid and glycolic acid, and the mixture is stirred and dispersed at a temperature of about room temperature to about 70 ° C for about 1 hour. Some of the solvent evaporates,
When triethyl citrate is sufficiently homogenized to a lactic acid polymer or a copolymer of lactic acid and glycolic acid, vacuum drying is performed at room temperature to 70 ° C. Without using an organic solvent, a lactic acid polymer or a copolymer of lactic acid and glycolic acid is 100 to 1
After heating to 50 ° C. and softening, triethyl citrate can be dispersed by stirring. In this case, the content of triethyl citrate must be in the range of 10 to 40% by weight based on the lactic acid copolymer or the copolymer of lactic acid and glycolic acid. In terms of the content, it becomes difficult to obtain the excellent material for treating periodontal disease of the present invention. That is, when the content of triethyl citrate is less than 10% by weight, the material is not softened, the adhesion to the biodegradable membrane is reduced, and a gap is formed between the biodegradable membrane and the tooth. Conversely, when the content of triethyl citrate exceeds 40% by weight, the material is not preferable because it is dissolved by the water such as a body fluid.

【0013】このようにして得られる本発明素材の使用
方法としては、予め生体内分解性膜にこれを付着させ、
ローラー等によってこれを均一に圧延し歯牙と固定して
もよいし、或は予め本発明の素材を歯牙に付着させ、生
体内分解性膜を固定してもよい。また、生体内分解性膜
と歯牙を固定させ、その間隙にこの素材を充填してもよ
い。尚、これらの方法を行う際に、本発明の素材中に抗
菌剤、経口防腐剤、抗生物質、局所麻酔剤あるいは生理
活性物質等を予め混合しておくことも可能である。
The method of using the material of the present invention obtained as described above is as follows.
This may be uniformly rolled with a roller or the like and fixed to the tooth, or the material of the present invention may be previously adhered to the tooth to fix the biodegradable membrane. Alternatively, the biodegradable membrane and the tooth may be fixed, and the gap may be filled with this material. In carrying out these methods, it is also possible to previously mix an antibacterial agent, an oral preservative, an antibiotic, a local anesthetic or a physiologically active substance in the material of the present invention.

【0014】[0014]

【実施例】以下に本発明の実施例を掲げ更に説明を行な
うが、本発明はこれらに限定されるものではない。ま
た、本発明実施例に於て%は特に断らない限り全て重量
%を示す。
The present invention will be further described below with reference to examples of the present invention, but the present invention is not limited to these examples. In the examples of the present invention, all percentages are by weight unless otherwise specified.

【0015】(実施例 1)塩化メチレン(関東化学(株)
製試薬)400mlに粉砕したD,L-乳酸重合体(数平均分子
量 27000)22gを加え室温で攪拌溶解させた。これにク
エン酸トリエチル(関東化学(株)製試薬)12gを添加
し、40℃に加温して混合した。重合体濃度が塩化メチレ
ンの揮散による重量変化により約10%になったところで
これをテフロンフィルム上に延伸させ、70℃で減圧乾燥
し本発明の素材を得た。尚、本発明の素材中のクエン酸
トリエチル含量は31%と求められた。
(Example 1) Methylene chloride (Kanto Chemical Co., Ltd.)
(Reagent made) 22 g of a pulverized D, L-lactic acid polymer (number average molecular weight 27000) was added to 400 ml and stirred and dissolved at room temperature. To this, 12 g of triethyl citrate (Kanto Chemical Co., Ltd. reagent) was added, and the mixture was heated to 40 ° C. and mixed. When the polymer concentration reached about 10% due to the change in weight due to the volatilization of methylene chloride, this was stretched on a Teflon film and dried at 70 ° C. under reduced pressure to obtain the material of the present invention. The content of triethyl citrate in the material of the present invention was determined to be 31%.

【0016】本発明の素材をツベルクリン用1ml容シリ
ンジ(テルモ社製)に充填し、これをドライヤーで約60
℃に加温軟化させ、別に製造したL-乳酸重合体(数平均
分子量 26000)からなる多孔性生体内分解性膜10mm×15
mm×150μm の片面端にシリンジを押し付けながらピス
トンを押し、1.5mm幅で付着させた。本発明の素材が付
着した多孔性生体内分解性膜をポリエチレン袋に入れ50
℃の温水に漬ける。5分間加温した後軟化させ付着部分
の厚みを均一化した。次いで膜からはみでた部分の素材
を切断した。
The material of the present invention is filled in a 1 ml syringe for tuberculin (manufactured by Terumo Corporation), and the mixture is dried with a drier for about 60 hours.
10mm × 15 porous biodegradable membrane made of L-lactic acid polymer (number average molecular weight 26000), which is softened by heating to ℃
The piston was pressed while pressing a syringe against one end of one side of mm × 150 μm, and attached with a width of 1.5 mm. Place the porous biodegradable membrane to which the material of the present invention is attached in a polyethylene bag
Soak in warm water at ℃. After heating for 5 minutes, it was softened and the thickness of the adhered portion was made uniform. Next, the part of the material protruding from the film was cut.

【0017】この本発明の素材を付着させた多孔性生体
内分解性膜を用い、雑種成犬の歯牙の標本を使用して素
材の性能評価を行った。評価方法は雑種成犬の歯牙の歯
根面を周着するように上記の膜で被覆した後、この周囲
を縫合糸で結び付けた。この部分に1%マラカイトグリ
ーン水溶液をスポイトで100ml滴下し、3時間後に膜を取
り外した結果、多孔性生体内分解性膜で覆われた部分に
はマラカイトグリーンの着色は全く見られず、本発明の
素材による膜の固定は良好に成されていた。
Using the porous biodegradable membrane to which the material of the present invention was adhered, the performance of the material was evaluated using a sample of a tooth of a hybrid dog. The evaluation method was such that the root of the tooth of a mongrel dog was covered with the above-mentioned film so as to cover the tooth root surface, and the periphery was tied with a suture. 100 ml of a 1% malachite green aqueous solution was dropped on this part with a dropper, and the membrane was removed after 3 hours. As a result, no coloration of malachite green was observed in the part covered with the porous biodegradable membrane. The fixation of the membrane with the above materials was well performed.

【0018】(比較例 1)D,L-乳酸重合体(数平均分子
量27000)をツベルクリン用1ml容シリンジ(テルモ社
製)に充填し、これをドライヤーで約80℃に加温軟化さ
せ、別に製造したL-乳酸重合体(数平均分子量 26000)
からなる多孔性生体内分解性膜10mm×15mm×150μm の
片面端にシリンジを押し付けながらピストンを押し、1.
5mm幅で付着させた。これをポリエチレン袋に入れ80℃
の温水に漬け、5分間加温し軟化させ付着部分の厚みを
均一化した。次いで膜からはみでた部分の素材を切断し
た。
(Comparative Example 1) D, L-lactic acid polymer (number average molecular weight 27000) was filled in a 1 ml syringe for tuberculin (manufactured by Terumo Corporation), and this was heated and softened to about 80 ° C. with a drier, L-lactic acid polymer produced (number average molecular weight 26000)
Press the piston while pressing the syringe against one end of a porous biodegradable membrane consisting of 10 mm × 15 mm × 150 μm consisting of 1.
It was attached with a width of 5 mm. Put this in a polyethylene bag at 80 ° C
Immersed in warm water and heated for 5 minutes to soften it and make the thickness of the adhered portion uniform. Next, the part of the material protruding from the film was cut.

【0019】この素材を付着させた多孔性生体内分解性
膜を用い、雑種成犬の歯牙の標本を使用して素材の性能
評価を行った。評価方法は雑種成犬の歯牙の歯根面を周
着するように上記の膜で被覆したが歯牙との接着性が悪
く、この部分に1%マラカイトグリーン水溶液をスポイ
トで100ml滴下し、3時間後に膜を取り外した結果、多孔
性生体内分解性膜で覆われた部分にはマラカイトグリー
ンの着色が見らた。このことから膜と歯牙とに間隙が生
じていたことが確認され、本発明の素材を使用した場合
と明らかに相違していた。
The performance of the material was evaluated using a porous biodegradable membrane to which the material was adhered and using a sample of a tooth of a hybrid adult dog. The evaluation method was that the tooth of the mongrel dog was covered with the above-mentioned film so as to cover the tooth root surface, but the adhesion to the tooth was poor, and 100 ml of a 1% malachite green aqueous solution was dropped on this part with a dropper, and after 3 hours As a result of removing the membrane, the portion covered with the porous biodegradable membrane was colored with malachite green. This confirmed that a gap was formed between the film and the teeth, which was clearly different from the case where the material of the present invention was used.

【0020】(実施例 2)塩化メチレン(関東化学(株)
製試薬)400mlに粉砕したL-乳酸含量が80モル%のL-乳
酸-グリコール酸共重合体(数平均分子量 90000)41gを
加え室温で攪拌溶解させた。これにクエン酸トリエチル
(関東化学(株)製試薬)28gを添加し、40℃に加温して
混合した。重合体濃度が重量変化により約20%になった
ところでこれをテフロンフィルム上に延伸させ、70℃で
減圧乾燥し本発明の素材を得た。尚、本発明の素材中の
クエン酸トリエチル含量は40%と求められた。
Example 2 Methylene chloride (Kanto Chemical Co., Ltd.)
(Reagent manufactured) 41 g of L-lactic acid-glycolic acid copolymer (number average molecular weight 90,000) pulverized to 400 ml and having an L-lactic acid content of 80 mol% was added and dissolved at room temperature with stirring. To this was added 28 g of triethyl citrate (a reagent manufactured by Kanto Chemical Co., Ltd.), and the mixture was heated to 40 ° C. and mixed. When the polymer concentration became about 20% due to weight change, it was stretched on a Teflon film and dried at 70 ° C. under reduced pressure to obtain the material of the present invention. The content of triethyl citrate in the material of the present invention was determined to be 40%.

【0021】この素材をツベルクリン用1ml容シリンジ
(テルモ社製)に充填し、これをドライヤーで約60℃に
加温軟化させ、別に製造したL-乳酸-グリコール酸共重
合体膜 (数平均分子量 131000,L-乳酸含量 78モル
%)からなる多孔性生体内分解性膜10mm×15mm×150μm
の片面端にシリンジを押し付けながらピストンを押
し、1.5mm幅で付着させた。
This material was filled in a 1 ml syringe for tuberculin (manufactured by Terumo Corporation), which was heated and softened to about 60 ° C. with a drier, and then separately manufactured L-lactic acid-glycolic acid copolymer film (number average molecular weight) 131000, L-lactic acid content 78 mol%), porous biodegradable membrane 10 mm x 15 mm x 150 μm
The piston was pressed while pressing a syringe against one end of the, and attached with a width of 1.5 mm.

【0022】この素材を付着させた多孔性生体内分解性
膜を用い、雑種成犬の歯牙の標本を使用して素材の性能
評価を行った。評価方法は雑種成犬の歯牙の歯根面を周
着するように上記の膜で被覆した後、この周囲を縫合糸
で結び付けた。この部分に1%マラカイトグリーン水溶
液をスポイトで100ml滴下し、3時間後に膜を取り外した
結果、多孔性生体内分解性膜で覆われた部分にはマラカ
イトグリーンの着色は全く見られず、本発明の素材によ
る膜の固定は良好に成されていた。
The performance of the material was evaluated using a porous biodegradable membrane to which the material was adhered and using a sample of a hybrid adult dog tooth. The evaluation method was such that the root of the tooth of a mongrel dog was covered with the above-mentioned film so as to cover the tooth root surface, and the periphery was tied with a suture. 100 ml of a 1% malachite green aqueous solution was dropped on this part with a dropper, and the membrane was removed after 3 hours. As a result, no coloration of malachite green was observed in the part covered with the porous biodegradable membrane. The fixation of the membrane with the above materials was well performed.

【0023】(実施例 3)塩化メチレン(関東化学(株)
製試薬)50mlに粉砕したD,L-乳酸含量が50モル%のD,L-
乳酸-グリコール酸共重合体(数平均分子量 45000)5.1
gを加え室温で攪拌溶解させた。これにクエン酸トリエ
チル(関東化学(株)製試薬)0.57gを添加し、40℃に加
温して混合した。重合体濃度が重量変化により約10%に
なったところでこれをテフロンフィルム上に延伸させ、
70℃で減圧乾燥し本発明の素材を得た。尚、本発明の素
材中のクエン酸トリエチル含量は10%と求められた。
Example 3 Methylene chloride (Kanto Chemical Co., Ltd.)
Reagents) D, L- crushed to 50 ml D, L-lactic acid content of 50 mol%
Lactic acid-glycolic acid copolymer (number average molecular weight 45,000) 5.1
g was added and dissolved by stirring at room temperature. To this, 0.57 g of triethyl citrate (a reagent manufactured by Kanto Chemical Co., Ltd.) was added, and the mixture was heated to 40 ° C. and mixed. When the polymer concentration became about 10% by weight change, stretched this on a Teflon film,
The material of the present invention was obtained by drying under reduced pressure at 70 ° C. The content of triethyl citrate in the material of the present invention was determined to be 10%.

【0024】この素材をツベルクリン用1ml容シリンジ
(テルモ社製)に充填し、これをドライヤーで約60℃に
加温軟化させ、別に製造したD,L-乳酸-グリコール酸共
重合体からなる多孔性生体内分解性膜(数平均分子量 2
51000、D,L-乳酸含量 59モル%)10mm×15mm×150μm
の片面端にシリンジを押し付けながらピストンを押し、
1.5mm幅で付着させた。この素材が付着した多孔性生体
内分解性膜をポリエチレン袋に入れ50℃の温水に漬け、
5分間加温した後付着部分の厚みを温度と水圧によって
均一化した。次いで膜からはみでた部分の素材を切断し
た。
This material was filled in a 1 ml syringe for tuberculin (manufactured by Terumo Co.), which was heated and softened to about 60 ° C. with a drier, and a porous material made of a separately prepared D, L-lactic acid-glycolic acid copolymer was prepared. Biodegradable membrane (number average molecular weight 2
51000, D, L-lactic acid content 59mol%) 10mm × 15mm × 150μm
Press the piston while pressing the syringe against one end of the
It was attached in a 1.5 mm width. Put the porous biodegradable membrane with this material attached in a polyethylene bag and soak in 50 ° C hot water,
After heating for 5 minutes, the thickness of the adhered portion was made uniform by temperature and water pressure. Next, the part of the material protruding from the film was cut.

【0025】この素材を付着させた多孔性生体内分解性
膜を用い、雑種成犬の歯牙の標本を使用して素材の性能
評価を行った。評価方法は雑種成犬の歯牙の歯根面を周
着するように上記の膜で被覆した後、この周囲を縫合糸
で結び付けた。この部分に1%マラカイトグリーン水溶
液をスポイトで100ml滴下し、3時間後に膜を取り外した
結果、多孔性生体内分解性膜で覆われた部分にはマラカ
イトグリーンの着色は全く見られず、本発明の素材によ
る膜の固定は良好に成されていた。また、実施例 3で得
られた本発明の素材が付着した生体内分解性膜を下顎 P
3、P4歯に5mmφの骨欠損を形成させた雑種成犬の歯根面
に装着させ、縫合糸であるコーティドバイクリル(coate
d Vicryl,エチコン社製商品名)で縫合糸8週間後に観察
した結果、上皮の侵入は見られず歯冠側へのセメント質
形成と新付着が見られ、膜の固定が良好になされてい
た。
Using the porous biodegradable membrane to which the material was attached, the performance of the material was evaluated using a sample of a hybrid adult dog tooth. The evaluation method was such that the root of the tooth of a mongrel dog was covered with the above-mentioned film so as to cover the tooth root surface, and the periphery was tied with a suture. 100 ml of a 1% malachite green aqueous solution was dropped on this part with a dropper, and the membrane was removed after 3 hours. As a result, no coloration of malachite green was observed in the part covered with the porous biodegradable membrane. The fixation of the membrane with the above materials was well performed. In addition, the biodegradable membrane to which the material of the present invention obtained in Example 3 was attached was attached to the lower jaw P.
3.Mounted on the tooth root surface of a hybrid adult dog with a 5 mmφ bone defect formed on the P4 tooth, and coated suture coated bicyclyl (coate
d Vicryl, a brand name of Ethicon Co.), 8 weeks after the suture, no epithelial invasion was observed, cementum formation and new adhesion to the crown side were observed, and the membrane was fixed well. .

【0026】[0026]

【発明の効果】本発明の歯周病治療用素材は、従来の素
材よりも柔軟性が高く、あらかじめ生体内分解性膜と付
着させた場合も膜に対する影響はなく、貯蔵安定性が高
い。また、生体組織反応もなく患者への負担も少なくて
すむ特徴を有する。また、生体内分解性膜として使用す
る乳酸系重合体からなる生体内分解性膜との付着性に優
れ、更に、歯牙との親和性が優れることから、生体内分
解性膜と歯牙との密着性に優れ、歯牙との間に隙を生じ
ず生体内に於いて膜の離脱、剥離が生じない特徴をも有
する。従ってこれらの特徴によって、本発明の素材は歯
周疾患により破壊された歯周組織の再生を良好にする場
を形成し、歯周病治療用素材として有用なものである。
The material for treating periodontal disease according to the present invention has higher flexibility than conventional materials, has no influence on the membrane even when it is previously attached to a biodegradable membrane, and has high storage stability. Further, there is a feature that there is no biological tissue reaction and the burden on the patient can be reduced. In addition, it has excellent adhesion to the biodegradable membrane made of a lactic acid-based polymer used as the biodegradable membrane, and furthermore, has excellent affinity with the teeth, so that the adhesion between the biodegradable membrane and the tooth is excellent. It has excellent properties and does not form a gap between teeth and does not cause detachment or peeling of the membrane in vivo. Therefore, due to these characteristics, the material of the present invention forms a place where the regeneration of periodontal tissue destroyed by periodontal disease is improved, and is useful as a material for treating periodontal disease.

───────────────────────────────────────────────────── フロントページの続き (72)発明者 永岡 陽一 兵庫県加古川市別府町新野辺1406−1番 地 審査官 生越 由美 (56)参考文献 特開 平1−104635(JP,A) 特開 平2−63465(JP,A) 特開 平4−231061(JP,A) 特開 平5−194189(JP,A) 特開 平1−113056(JP,A) (58)調査した分野(Int.Cl.7,DB名) A61C 19/06 A61K 6/00 A61K 31/765 ACK ────────────────────────────────────────────────── ─── Continuation of front page (72) Inventor Yoichi Nagaoka 1406-1 Shinnobe, Beppu-cho, Kakogawa-shi, Hyogo Examiner Yumi Ogoshi (56) References JP-A-1-104635 (JP, A) JP-A-2-63465 (JP, A) JP-A-4-231061 (JP, A) JP-A-5-194189 (JP, A) JP-A 1-113056 (JP, A) (58) Fields investigated (Int .Cl. 7 , DB name) A61C 19/06 A61K 6/00 A61K 31/765 ACK

Claims (3)

(57)【特許請求の範囲】(57) [Claims] 【請求項1】 主構成成分として、乳酸重合体又は乳酸
とグリコール酸との共重合体にクエン酸トリエチルを含
有せしめた成分からなる歯周病治療用素材。
1. A material for treating periodontal disease, comprising, as a main component, a component obtained by adding triethyl citrate to a lactic acid polymer or a copolymer of lactic acid and glycolic acid.
【請求項2】 乳酸重合体又は乳酸とグリコール酸との
共重合体の数平均分子量が10,000〜90,000の範囲である
請求項1の歯周病治療用素材。
2. The material for treating periodontal disease according to claim 1, wherein the number average molecular weight of the lactic acid polymer or the copolymer of lactic acid and glycolic acid is in the range of 10,000 to 90,000.
【請求項3】 乳酸重合体又は乳酸とグリコール酸との
共重合体に対するクエン酸トリエチルの含量が10〜40重
量%の範囲である請求項1の歯周病治療用素材。
3. The material for treating periodontal disease according to claim 1, wherein the content of triethyl citrate relative to the lactic acid polymer or the copolymer of lactic acid and glycolic acid is in the range of 10 to 40% by weight.
JP20714892A 1992-07-10 1992-07-10 Materials for treating periodontal disease Expired - Fee Related JP3217861B2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
JP20714892A JP3217861B2 (en) 1992-07-10 1992-07-10 Materials for treating periodontal disease

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
JP20714892A JP3217861B2 (en) 1992-07-10 1992-07-10 Materials for treating periodontal disease

Publications (2)

Publication Number Publication Date
JPH0638992A JPH0638992A (en) 1994-02-15
JP3217861B2 true JP3217861B2 (en) 2001-10-15

Family

ID=16535011

Family Applications (1)

Application Number Title Priority Date Filing Date
JP20714892A Expired - Fee Related JP3217861B2 (en) 1992-07-10 1992-07-10 Materials for treating periodontal disease

Country Status (1)

Country Link
JP (1) JP3217861B2 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2002020530A (en) * 2000-07-05 2002-01-23 Toyo Cloth Co Ltd Biodegradable porous membrane, structural material and method for producing the same
CN1317321C (en) * 2005-04-15 2007-05-23 浙江工业大学 Method for plasticizing resin granules of poly lactic acid

Also Published As

Publication number Publication date
JPH0638992A (en) 1994-02-15

Similar Documents

Publication Publication Date Title
JP5684140B2 (en) Ascorbic acid phosphate sustained release system
CA1186625A (en) Collagen-enzyme conjugates that exhibit no inflammatory response and method for making same
DE3689650T2 (en) High molecular weight bioabsorbable polymers and implants thereof.
DE69737909T2 (en) POLYMERIZABLE BIODEGRADABLE POLYMERS WITH CARBONATE OR DIOXANONE BINDINGS
EP1430917B1 (en) Compositions and medical devices utilizing bioabsorbable polymeric waxes
US5061281A (en) Bioresorbable polymers and implantation devices thereof
DE3928933C2 (en) Use of a periodontium regenerating material
US20060210747A1 (en) Compositions and medical devices utilizing bioabsorbable polymeric waxes
US7449498B2 (en) Composite materials for bone defect filling and bone replacement
JPH05504941A (en) Biodegradation system for periodontal tissue regeneration
EP0857072A1 (en) Implantable bioresorbable membrane and method for the preparation thereof
JP2805086B2 (en) Filler for living tissue
DE69308561T2 (en) USE OF LACTIC ACID POLYMERS FOR THE PRODUCTION OF BIORESORBIBLE MEMBRANES FOR THE CONTROLLED TISSUE GENERATION, IN PARTICULAR FOR PERIODONTOLOGY
JP3689112B2 (en) Alginate fiber, its production and use
JP3217861B2 (en) Materials for treating periodontal disease
JP3037793B2 (en) Material for treating periodontal disease
US6169046B1 (en) Absorbable barrier membrane
JPH0564982B2 (en)
KR20200121446A (en) Bone graft material for regenerating periodontal tissue and manufacturing method thereof
JP2508105B2 (en) Biodegradable and absorbable antithrombotic medical material and method for producing the same
JP2583173B2 (en) Wound dressing
US20230263937A1 (en) Biomaterial comprising at least one elastomeric matrix and a non-sulfated polysaccharide and uses thereof
JP3712765B2 (en) Bioabsorbable barrier membrane
EP2886134A1 (en) Resorbable implant
JPH0499725A (en) Drug for promoting reproduction of periodontium

Legal Events

Date Code Title Description
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20010724

R250 Receipt of annual fees

Free format text: JAPANESE INTERMEDIATE CODE: R250

LAPS Cancellation because of no payment of annual fees